Next Article in Journal
C-type Lectin Receptors for Tumor Eradication: Future Directions
Next Article in Special Issue
Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment
Previous Article in Journal
Current Perspectives on Desmoid Tumors: The Mayo Clinic Approach
Previous Article in Special Issue
Toll-Like Receptor 4 Signaling Integrates Intestinal Inflammation with Tumorigenesis: Lessons from the Murine Model of Colitis-Associated Cancer
Cancers 2011, 3(3), 3156-3168; doi:10.3390/cancers3033156
Article

Upregulation of Leukotriene Receptors in Gastric Cancer

1
,
2
,
1
,
3
,
1,*  and 1
1 Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Leipziger Str. 44, Magdeburg 39120, Germany 2 Institute of Pathology, Otto-von-Guericke University, Leipziger Str. 44, Magdeburg 39120, Germany 3 Department of General, Visceral and Vascular Surgery, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, Magdeburg 39120, Germany
* Author to whom correspondence should be addressed.
Received: 10 June 2011 / Revised: 2 August 2011 / Accepted: 4 August 2011 / Published: 8 August 2011
(This article belongs to the Special Issue Exploring Inflammation in Cancers)
View Full-Text   |   Download PDF [390 KB, uploaded 8 August 2011]   |   Browse Figures

Abstract

Background: Leukotrienes (LT) mediate allergic and inflammatory processes. Previously, we identified significant changes in the expression pattern of LT receptors in the gastric mucosa after eradication of Helicobacter pylori infection. The aim of the present study was to evaluate the expression of 5-lipoxygenase (5-LOX) and LT receptors in gastric cancer (GC). Methods: The expression of 5-LOX and receptors for LTB4 (BLT-1, BLT-2) and cysteinyl-LT (CysLT-1, CysLT-2) were analyzed by immunohistochemistry (IHC) in GC samples of 35 consecutive patients who underwent gastrectomy and in 29 tumor-free tissue specimens from gastric mucosa. Results: Male-to-female ratio was 24:11. The median age was 70 years (range 34–91). Twenty-two patients had GC of intestinal, six of diffuse, six of mixed and one of undifferentiated type. The IHC analysis showed a nearly ubiquitous expression of studied proteins in GC (88–97%) and in tumor-free specimens as well (89–100%). An increase in the immunoreactive score of both BLT receptors and CysLT-1 was observed in GC compared to tumor-free gastric mucosa (p < 0.001 for BLT-1; p < 0.01 for BLT-2 and CysLT-1, Mann-Whitney U-test). No differences in the IHC expression of 5-LOX and CsyLT-2 were observed between GC and tumor-free mucosa. The expression of BLT-2, CysLT-1 and CysLT-2 was increased in GC of intestinal type when compared to the diffuse type (p < 0.05; Mann-Whitney U-test). Conclusions: LTB4 receptors and CysLT-1 are up-regulated in GC tissue implying a role in gastric carcinogenesis.
Keywords: leukotriene receptors; gastric cancer; cysteinyl-leukotrienes leukotriene receptors; gastric cancer; cysteinyl-leukotrienes
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Venerito, M.; Kuester, D.; Harms, C.; Schubert, D.; Wex, T.; Malfertheiner, P. Upregulation of Leukotriene Receptors in Gastric Cancer. Cancers 2011, 3, 3156-3168.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert